Jane Street
IRLA

Jane Street’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Jane Street’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-243
Closed -$301K – 10620
2022
Q1 		$301K Sell
243
-572
-70% -$778K ﹤0.01% 8402
2021
Q4 		$2.06M Buy
815
+452
+125% +$2.76M ﹤0.01% 4430
2021
Q3 		$6.64M Buy
363
+320
+744% +$5.09M ﹤0.01% 2339
2021
Q2 		$451K Buy
+43
New +$361K ﹤0.01% 7433

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's IRLA Position: Q2 2026 in Review

Jane Street opened a new position in IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026: 12,642 shares worth $230K. The stake represents ﹤0.01% of the portfolio and ranks #9795 among its holdings. This is a return to the name: Jane Street previously reported a position in IRLA as recently as Q4 2025.

Jane Street first reported a position in IRLA in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.13M in Q3 2021. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

  • Jane Street held 12,642 shares of IRulya Therapeutics Inc. Common Stock worth $230K as of Q2 2026.
  • IRulya Therapeutics Inc. Common Stock was a new Jane Street position in Q2 2026.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9795 holding.
  • Jane Street first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2020 and has held it in 9 quarters since.
  • Jane Street's IRulya Therapeutics Inc. Common Stock position peaked at $2.13M in Q3 2021.
  • 26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.